e-Therapeutics, a pioneering network pharmacology company focused on drug discovery and development, has appointed Dr Daniel Elger as chief financial officer (CFO).
Previously, Elger was vice president, marketing and communications at cancer drug developer Antisoma. He joined that company in 2002 and served on its senior management team from 2005, playing significant roles in corporate strategy, fundraisings and the acquisition of two US biotech companies. He also directed the investor relations strategy for the company.
Before Antisoma, Elger was a programme director for major pharmaceutical companies at a leading marketing and communications agency. He holds a BA in Physiological Sciences (Medicine) and a PhD in cancer cell biology, both from Oxford University.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more